# The Meaning of Dopaminergic Pathway in Sleep Breathing Disorders.

> **NCT05890911** · — · ENROLLING_BY_INVITATION · sponsor: **Wroclaw Medical University** · enrollment: 100 (estimated)

## Conditions studied

- Sleep Apnea
- Sleep-Disordered Breathing

## Interventions

- **DIAGNOSTIC_TEST:** Polysomnography
- **DIAGNOSTIC_TEST:** Blood dopamine level measurement
- **DIAGNOSTIC_TEST:** Genetical test

## Key facts

- **NCT ID:** NCT05890911
- **Lead sponsor:** Wroclaw Medical University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2023-06-01
- **Primary completion:** 2026-05
- **Final completion:** 2026-12
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2026-02-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05890911

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05890911, "The Meaning of Dopaminergic Pathway in Sleep Breathing Disorders.". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05890911. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*